Head and Neck Imaging Surveillance Strategy for HPV-positive Oropharyngeal Carcinoma Following Definitive (Chemo)Radiotherapy.
CONCLUSIONS: Pattern of HN imaging utilization for surveillance varied significantly among clinicians. Imaging surveillance reduces the need for ND. However, routine HN-CT/MR surveillance without clinical symptoms/signs does not demonstrate proven value in identifying locoregional failure or toxicity. Radiologic "residual" LNs without adverse features are common. If two subsequent follow-up scans demonstrate stable/regressing radiologic "residual" LNs, clinical surveillance without further imaging appears to be safe in this population.
PMID: 33600871 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Wong ET, Hui Huang S, O'Sullivan B, Persaud V, Su J, Waldron J, Goldstein DP, de Almeida J, Ringash J, Kim J, Hope A, Bratman S, Cho J, Giuliani M, Hosni A, Spreafico A, Hansen A, Tong L, Xu W, Yu E Tags: Radiother Oncol Source Type: research
More News: Cancer & Oncology | Carcinoma | Genital Warts | Human Papillomavirus (HPV) | Oropharyngeal Cancer | PET Scan | Radiology | Toxicology